No Data
No Data
Acelyrin | 10-Q: Q1 2025 Earnings Report
Sector Update: Health Care Stocks Decline Tuesday Afternoon
Lumis Stockholders Approve All Proposals Required To Be Approved In Connection With Pending Merger With ACELYRIN; Merger Is Expected To Close In Q2 2025
Express News | Alumis Inc - Merger Expected to Close in Q2 2025
Express News | ACELYRIN Stockholders Approve Merger With Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-Mediated Diseases
ACELYRIN Stockholders Approve Merger With Alumis To Create Clinical Biopharma Company Dedicated To Innovating, Developing And Commercializing Transformative Therapies For Immune-mediated Diseases >SLRN